THE RESCUE THERAPY COMPANY
Home
About
Mission and Vision
Corporate Values
Our People
Board and Management
Our Products
Investor Relations
ASX and Press Releases
Annual and Half Year Reports
Corporate Kit
Corporate Governance
Shareholder Services
Contact Us
2014
06/03/14 - Giaconda’s Picoconda Licensed by Redhill
2012
23/08/12 - ASX Market Release - Suspension
25/07/12 - Expiry of Options
13/02/12 - Sharehodler and Creditor Update
2011
24/11/11 - Shareholder and Creditor Update
01/11/11 - Shareholder and Creditor Update
21/04/11 - Deed of Company Arrangement
23/03/11 - Notice of Second Creditors Meeting
16/03/11 - Release of Registered Securities
02/03/11 - Terms of Administrator`s proposed appointment
02/03/11 - Convening of first creditors meeting
5/02/11 - Half Yearly Report and Accounts
25/02/11 - SUSPENSION FROM OFFICIAL QUOTATION
25/02/11 - APPOINTMENT OF VOLUNTARY ADMINISTRATOR
24/02/11 - Trading Halt Request
24/02/11 - Trading Halt
10/02/11 - ASX Appendix 4C query and response
01/02/11 - Appendix 4C - quarterly - Q2FY11
05/01/11 - Appendix 3B - Updated options
2010
31/12/10 - Updated Share Trading Policy
01/12/10 - Results of Meeting - 2010 AGM
30/11/10 - Chairman`s Address to Shareholders - 2010 AGM
16/11/10 - Notice of Annual General Meeting/Proxy Form
10/11/10 - Response to ASX Query - Appendix 4C
28/10/10 - Annual Report to shareholders - Erratum
28/10/10 - Annual Report to shareholders - Directors` Declaration
28/10/10 - Annual Report to shareholders
27/10/10 - Appendix 4C - quarterly
01/10/10 - Appendix 3B
29/09/10 - Full Year Statutory Accounts-FY10
31/08/10 - Preliminary Final Report - FY2010
31/08/10 - RedHill Completion
17/08/10 - Disclosure Document - Red Hill Sale
11/08/10 - ASX Appendix 4C query and response
02/08/10 - Disclosure Document - 4C for FY10
02/07/10 - Change of Director`s Interest Notice Borody Form 604
01/07/10 - Change of Director`s Interest Notice - McLean 3Y
01/07/10 - Change of Director`s Interest Notice - Borody
16/06/10 - AMTI Termination
16/06/10 - Proposed Sale of Intellectual Property
24/05/10 - Appendix 4C Query and Response
17/05/10 - Disclosure Document - AMTI Completion
03/05/10 - Appendix 4C - quarterly
23/04/10 - Disclosure Document - Heliconda License
19/04/10 - Disclosure Document - Asset Purchase Update
19/04/10 - Disclosure Document - Patent Status
01/04/10 - Appendix 3B
19/03/10 - Disclosure Document - AMTI Asset Purchase Delay
09/03/10 - Disclosure Document - Asset and Share Sale Update
02/03/10 - Appendix 3B - Further Revisions
02/03/10 - Disclosure Document - Research Collaboration
22/02/10 - Appendix 3B Corrections
19/02/10 - Becoming a substantial holder
18/02/10 - Notice under Section 708A
18/02/10 - Sale of Myoconda and Share Placement
18/02/10 - Appendix 3B
6/02/10 - Half Yearly Report and Accounts
11/02/10 - Notice under Section 708A
09/02/10 - Details of Company Address
05/02/10 - Company Secretary Resignation
05/02/10 - Loan Facility Repayment
05/02/10 - Appendix 3B
02/02/10 - ASX Appendix 4C Query and Response
29/01/10 - Appendix 4C - quarterly
2009
27/11/09 - Results of AGM
24/11/09 - AGM Presentation
30/10/09 - Appendix 4C - quarterly
23/10/09 - Alteration to Notice of Meeting
23/10/09 - Notice of Annual General Meeting/Proxy Form
23/10/09 - Annual Report to shareholders
30/09/09 - Full Year Statutory Accounts
27/08/09 - Preliminary Final Report
31/07/09 - Appendix 4C - quarterly
05/05/09 - Company Secretary Appointment
04/05/09 - Giaconda Secures New Financing Facility
30/04/09 - Appendix 4C - quarterly
02/03/09 - Half Yearly Report and Accounts
02/02/09 - Response to ASX Query - Appendix 4C
29/1/09 - Quarterly Report - Appendix 4C
29/1/09 - Director Appointment & Resignation
29/1/09 - Final Directors Interest Notice
29/1/09 - Initial Directors Interest Notice
2008
1/12/08 - AGM Results
1/12/08 - AGM Presentation
1/12/08 - AGM Chairman’s speech
31/10/08 - Share Subscription Agreement Termination and Restriction
Agreement Expiry
28/10/08 - Appendix 4C – Quarterly Report
28/10/08 - AGM Notice & Proxy Form
28/10/08 - Annual Report 08
23/10/08 - Chairman resignation
23/10/08 - Final Directors Interest Notice
1/9/08 - Appendix 4E Preliminary Final Report
5/8/08 - Change of Director’s Interest Notice
22/7/08 - Giaconda announces proposal for share placement
14/7/08 - Appendix 4C
9/7/08 - Giaconda Suspends Hepaconda® Phase II Trial
to Carry Out Dose Ranging
20/6/08 - Appendix 3Y Moore
20/6/08 - Appendix 3Y Moon
20/6/08 - Appendix 3Y Woods
20/6/08 - Appendix 3B
7/4/08 - Giaconda Receives European Patent for Myoconda®
11/3/08 - Half Year Report ended 31 Dec 2007
3/3/08 - Appendix 4D and Half Year Results
19/2/08 - Appendix 3Y (3)
19/2/08 - Appendix 3Y(2)
19/2/08 - Appendix 3Y (1)
19/2/08 - Appendix 3B
19/2/08 - Clinical Trial Pilot Results
8/2/08 - Giaconda has commenced next round of fundraising
29/1/08 - Appendix 4C
22/1/08 - Heliconda® Patent Granted
2007
6/11/07 - Appendix 4C
29/10/07 - AGM Chairman's Speech
29/10/07 - AGM CEO's Speech
29/10/07 - AGM CMO's Presentation
24/9/07 - Clinical Trial Clarification
19/9/07 - Giaconda Signs Agreement to Take Myoconda® to Market in Europe
14/9/07 - Release of restricted securities from escrow on 27.09.07 and Appendix 3B
11/9/07 - 2007 Notice of AGM, Explanatory Memorandum and Proxy Form
11/9/07 - 2007 Annual Report
3/9/07 - Giaconda Appoints New Company Secretary
3/9/07 - Intersuisse analyst report on Giaconda Limited
28/8/07 - FY07 Appendix 4E Preliminary Final Report
27/8/07 - Hepaconda gains recognition as a promising drug
17/8/07 - Giaconda – office relocation and personnel change
23/7/07 - July 2007 Presentation – Company Update to Analysts
19/7/07 - Appendix 4C, Commitments Test Entity – Fourth Quarter Report
19/7/07 - Appendix 3B – Issue of Shares
19/7/07 - Appendix 3Y – Change of Director’s Interest Notice (T. Moon)
19/7/07 - Appendix 3Y – Change of Director’s Interest Notice (T. Moore)
19/7/07 - Appendix 3Y – Change of Director’s Interest Notice (R. Woods)
18/7/07 - Australian study of anti-MAP treatment in Crohn’s Disease published showing highest ever remission rates
4/7/07 - Lapsed Employee Options
25/6/07 - Commencement of PhIIa clinical trial for Hepaconda® in Hepatitis C
7/5/07 - Giaconda appoints new COO
24/4/07 - FDA approves Myoconda® IND for MAP in Crohn’s Disease
18/4/07 - Commitments Test Entity – Third Quarter Report
4/4/07 - Appendix 3B (Issue of Shares)
4/4/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moon)
4/4/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moore)
4/4/07 - Appendix 3Y Change in Directors’ Interests Notice (R. Woods)
22/3/07 - Peer reviewed journal paper supports use of Giaconda’s lead product Myoconda® for Crohn’s Disease
19/2/07 - Appendix 3B (Issue of Shares)
19/2/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moore)
19/2/07 - Appendix 3Y Change in Directors’ Interests Notice (T. Moon)
19/2/07 - Appendix 3Y Change in Directors’ Interests Notice (R. Woods)
13/2/07 - Half-Year FY07 Results
13/2/07 - Half-Year Report and Half-Year Accounts ended 31 Dec 2006
9/2/07 - Corporate Governance – amendment to contingent liabilities
18/1/07 - Commitments Test Entity – Second Quarter FY07
2006
28/12/06 - Giaconda receives European patent for Ibaconda
22/12/06 - Clarification of Options issued by Giaconda
22/12/06 - Appendix 3B (Issue of Shares)
22/12/06 - Appendix 3X Initial Director’s Interest Notice (T. Moore)
22/12/06 - Appendix 3Y Change in Director's Interests Notice (A. Moon)
22/12/06 - Appendix 3Y Change in Director's Interests Notice (R. Woods)
19/12/06 - Newsletter Issue 2 – December 2006
9/11/06 - Giaconda receives European patent for Heliconda®
31/10/06 - Results of 2006 AGM
30/10/06 - Chairman’s Address at AGM to Shareholders
30/10/06 - CEO’s Speech at AGM
30/10/06 - CMO’s Presentation at AGM
24/10/06 - Giaconda announces Myoconda® poster presentation at American College of Gastroenterology meeting
19/10/06 - Commitments Test Entity – First Quarter FY07
18/10/06 - Giaconda announces positive Phase II data for Picoconda presented at AGW
17/10/06 - Giaconda signs non-binding letter of intent for Myoconda® active ingredient
28/9/06 - 2006 Annual Report
28/9/06 - Notice of 2006 AGM
26/9/06 - Giaconda signs non-binding letter of intent for Myoconda
®
commercialisation in Benelux territory
14/9/06 - Appendix 4E Preliminary Final Report
14/9/06 - Financial year ends with a positive outlook for 2007
24/8/2006 - Appendix 3Z - Final Director's Interest Notice
23/8/2006 - Giaconda appoints new Chairman
17/8/2006 - Appendix 3B - Issue of Options
01/08/2006 - Change of Director’s Interest Notice
01/08/2006 - Second Non-binding Loi for Commercialisation of Myoconda®
28/07/2006 - Commitments Test Entity – Fourth Quarter
28/07/2006 - Cessation/Appointment of Company Secretary
27/06/2006 -
ASX Announcement of June 2006 Roadshow
19/05/2006 - Signs Service Agreement with CDD for Prof Borody
25/04/2006 - Commitments Test Entity - Third Quarter Report
13/04/2006 - Non-binding commercialisation LOI for Myoconda®® in UK
10/03/2006 - Newsletter Issue 1
10/03/2006 - Half Yearly Report and Half Year Accounts ended 31 Dec 2005
09/03/2006 - Hepaconda Patent Update
28/02/2006 - Amended initial Director's Interest Notice
06/02/2006 - Giaconda signs LOI with ICON for Myoconda® Phase IIIb study
06/02/2006 - Appendix 3B - Issue of options
31/01/2006 - Second Quarter Report
30/01/2006 - Heliconda Phase II study results published
18/01/2006 - Myoconda® Phase II study update
17/01/2006 - First Scientific Advisory Board Meeting held
2005
21/12/2005 - Appointment of Asst Company Secretary & CAO
14/12/2005 - Giaconda meets FDA & MHRA supported by BioBusiness Grant
30/11/2005 - Holds First AGM
23/11/2005 - Supplement to Results of AGM
18/11/20005 - Results of AGM
13/10/2005 - AGM Notice 2005
13/10/2005 - Signed Full 2005 Accounts
06/10/2005 - Amended Initial Director's Interest Notice
05/10/2005 - Initial Director's Interest Notice x6
04/10/2005 - Nobel Prize Confirms Giaconda's Direction
26/09/2005 - Company Secretary Resignation/Appointment
23/09/2005 - Terms & conditions of options to Messrs Allen & Hare
23/09/2005 - Securities subject to escrow & voluntary escrow
23/09/2005 - Appendix 1A - ASX Listing application & agreement
23/09/2005 - Constitution
23/09/2005 - Audited accounts for year ended 30 June 2004
23/09/2005 - Audited accounts for year ended 30 June 2005
23/09/2005 - Updated Statement of Commitment
23/09/2005 - Top 20 shareholders
23/09/2005 - Distribution Schedule
23/09/2005 - Pre-Quotation Disclosure
23/09/2005 - ASX Circular: Commencement of Official Quotation
23/09/2005 - Admission to Official List